Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04903470Not ApplicableRecruiting

Defecation Patterns in Constipated Patients

Role: lead

NCT05807321Not ApplicableRecruiting

Fecobionics in Biofeedback Therapy in Dyssynergia Patients

Role: lead

NCT05412069Not ApplicableRecruiting

Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Role: lead

NCT04766138Not ApplicableCompleted

Trial to Evaluate Fecobionics in Healthy Subjects and Patients

Role: lead

NCT06883175Not ApplicableRecruiting

Evolution of the Chicago Classification: Bridging Physiology and Mechanics

Role: collaborator

All 5 trials loaded